Skye Bioscience, Inc. (SKYE) SEC Filings https://ir.skyebioscience.com/sec-filings/section-16-filings/rss Skye Bioscience, Inc. (SKYE) - Section 16 Filings en-us https://d1io3yog0oux5.cloudfront.net/_e076ea37d6bf897725c32eff044cb88a/skyebioscience/files/theme/images/logo-sm.png Skye Bioscience, Inc. Logo Equisolve Investor Relations Suite <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023358/0001628280-26-023358.pdf Thu, 02 Apr 26 00:00:00 -0400 https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023358/0001628280-26-023358.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023356/0001628280-26-023356.pdf Thu, 02 Apr 26 00:00:00 -0400 https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023356/0001628280-26-023356.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023354/0001628280-26-023354.pdf Thu, 02 Apr 26 00:00:00 -0400 https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023354/0001628280-26-023354.pdf <![CDATA[3/A - Initial statement of beneficial ownership of securities]]> https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023351/0001628280-26-023351.pdf Thu, 02 Apr 26 00:00:00 -0400 https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023351/0001628280-26-023351.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023349/0001628280-26-023349.pdf Thu, 02 Apr 26 00:00:00 -0400 https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023349/0001628280-26-023349.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023346/0001628280-26-023346.pdf Thu, 02 Apr 26 00:00:00 -0400 https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023346/0001628280-26-023346.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023343/0001628280-26-023343.pdf Thu, 02 Apr 26 00:00:00 -0400 https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023343/0001628280-26-023343.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023340/0001628280-26-023340.pdf Thu, 02 Apr 26 00:00:00 -0400 https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023340/0001628280-26-023340.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023337/0001628280-26-023337.pdf Thu, 02 Apr 26 00:00:00 -0400 https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023337/0001628280-26-023337.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-006631/0001628280-26-006631.pdf Mon, 09 Feb 26 00:00:00 -0500 https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-006631/0001628280-26-006631.pdf